OmniAb, Inc. (OABI) Q2 FY26 Earnings Call

Raised guidance and expanding clinical milestones strengthen the model, but revenue remains milestone-driven and quarterly variable.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-06
Length47 minutes
EPS$-0.05
EPS consensus$-0.11
Revenue$13.4M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26

All OABI earnings ยท Back to OABI overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.